2-Amino-6-(2-butoxy-6-hydroxy-phenyl)-1',2',3',4',5',6'-hexahydro-[4,4']bipyridinyl-3-carbonitrile | 740792-29-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-Amino-6-(2-butoxy-6-hydroxy-phenyl)-1',2',3',4',5',6'-hexahydro-[4,4']bipyridinyl-3-carbonitrile
• 英文别名: 2-Amino-6-(2-butoxy-6-hydroxyphenyl)-4-(4-piperidinyl)-3-pyridinecarbonitrile；2-amino-6-(2-butoxy-6-hydroxyphenyl)-4-piperidin-4-ylpyridine-3-carbonitrile
• CAS: 740792-29-4
• 化学式: C₂₁H₂₆N₄O₂
• 分子量: 366.463
• InChiKey: KUSNFPNHSNUZPP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  27
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  104
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  1-(2-butoxy-6-hydroxyphenyl)ethanone 在 盐酸 、 ammonium acetate 、 四丁基碘化铵 作用下， 以 1,4-二氧六环 、 丙酮 为溶剂， 生成 2-Amino-6-(2-butoxy-6-hydroxy-phenyl)-1',2',3',4',5',6'-hexahydro-[4,4']bipyridinyl-3-carbonitrile
  参考文献：
  名称：

  Synthesis and structure–activity relationships of novel IKK-β inhibitors. Part 3: Orally active anti-inflammatory agents

  摘要：

  A series of 2-amino-3-cyano-4-alkyl-6-(2-hydroxyphenyl)pyridine derivatives was synthesized and evaluated as IkappaB kinase beta (IKK-beta) inhibitors. Modification of a novel IKK-beta inhibitor 1 (IKK-beta IC50 = 1500 nM, Cell IC50 = 8000 nM) at the 4-phenyl ring and 6-phenol group on the pyridine core ring resulted in a marked increased in biological activities. An optimized compound, 2-amino-6-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-4-piperidin-4-yl nicotinonitrile, exhibited excellent in vitro profiles (IKK-beta IC50 = 8.5 nM, Cell IC50 = 60 nM) and a strong oral efficacy in in vivo anti-inflammatory assays (significant effects at 1 mg/kg, po in arachidonic acid-induced ear edema model in mice). (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.05.041

文献信息

• US7232909B2
  申请人：——

  公开号：US7232909B2

  公开（公告）日：2007-06-19
• US7435743B2
  申请人：——

  公开号：US7435743B2

  公开（公告）日：2008-10-14
• Synthesis and structure–activity relationships of novel IKK-β inhibitors. Part 3: Orally active anti-inflammatory agents
  作者：Toshiki Murata、Mitsuyuki Shimada、Sachiko Sakakibara、Takashi Yoshino、Tsutomu Masuda、Takuya Shintani、Hiroki Sato、Yuji Koriyama、Keiko Fukushima、Noriko Nunami、Megumi Yamauchi、Kinji Fuchikami、Hiroshi Komura、Akihiko Watanabe、Karl B Ziegelbauer、Kevin B Bacon、Timothy B Lowinger

  DOI：10.1016/j.bmcl.2004.05.041

  日期：2004.8

  A series of 2-amino-3-cyano-4-alkyl-6-(2-hydroxyphenyl)pyridine derivatives was synthesized and evaluated as IkappaB kinase beta (IKK-beta) inhibitors. Modification of a novel IKK-beta inhibitor 1 (IKK-beta IC50 = 1500 nM, Cell IC50 = 8000 nM) at the 4-phenyl ring and 6-phenol group on the pyridine core ring resulted in a marked increased in biological activities. An optimized compound, 2-amino-6-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-4-piperidin-4-yl nicotinonitrile, exhibited excellent in vitro profiles (IKK-beta IC50 = 8.5 nM, Cell IC50 = 60 nM) and a strong oral efficacy in in vivo anti-inflammatory assays (significant effects at 1 mg/kg, po in arachidonic acid-induced ear edema model in mice). (C) 2004 Elsevier Ltd. All rights reserved.